Sanofi (OTCMKTS:SNYNF) Stock Price Down 1.2% – Here’s Why
by Doug Wharley · The Cerbat GemSanofi (OTCMKTS:SNYNF – Get Free Report) dropped 1.2% during mid-day trading on Friday . The company traded as low as $95.28 and last traded at $95.28. Approximately 344 shares changed hands during trading, a decline of 99% from the average daily volume of 33,517 shares. The stock had previously closed at $96.4650.
Sanofi Price Performance
The company’s fifty day simple moving average is $98.65 and its two-hundred day simple moving average is $97.47.
Sanofi Company Profile
Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.
In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.